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Japanese encephalitis is characterized by profound neuronal destruction/dysfunction and
concomitant microgliosis/astrogliosis. Although substantial activation of glia is observed in
Japanese encephalitis virus (JEV)-induced Japanese encephalitis, the inflammatory responses and
consequences of astrocytes and microglial activation after JEV infection are not fully understood.
In this study, infection of cultured neurons/glia with JEV caused neuronal death and glial
activation, as evidenced by morphological transformation, increased cell proliferation and elevated
tumour necrosis factor (TNF)-a, interleukin (IL)-1b, IL-6 and RANTES (regulated upon activation,
normal T-cell expressed and secreted) production. Replication-competent JEV caused all glial
responses and neurotoxicity. However, replication-incompetent JEV lost these abilities, except for
the ability to change microglial morphology. The bystander damage caused by activated glia also
contributed to JEV-associated neurotoxicity. Microglia underwent morphological changes,
increased cell proliferation and elevated TNF-a, IL-1b, IL-6 and RANTES expression in response
to JEV infection. In contrast, IL-6 and RANTES expression, but no apparent morphological
changes, proliferation or TNF-a/IL-1b expression, was demonstrated in JEV-infected astrocytes.
Supernatants of JEV-infected microglia, but not JEV-infected astrocytes, induced glial activation
and triggered neuronal death. Antibody neutralization studies revealed that TNF-a and IL-1b, but
not RANTES or IL-6, released by activated microglia appeared to play roles in JEV-associated
neurotoxicity. In conclusion, following JEV infection, neuronal death was accompanied by
concomitant microgliosis and astrogliosis, and neurotoxic mediators released by JEV-activated
microglia, rather than by JEV-activated astrocytes, had the ability to amplify the microglial
response and cause neuronal death.
INTRODUCTION
The central nervous system (CNS) consists of an intrinsic
network of neurons and glia. The CNS response to
ischaemia, degenerative diseases and viral infection is largely
manifested by neuronal loss and inflammatory responses
(Gao et al., 2002; Liao et al., 2002; Chen et al., 2004; Raung
et al., 2005; German et al., 2006; Ovanesov et al., 2006;
Ghoshal et al., 2007; van Marle et al., 2007; Saxena et al.,
2008; Swarup et al., 2008). Generally, the onset and/or
interactive crosstalk of neuronal injury and neuroinflamma-
tion play a critical role in the pathogenesis of neurological
disorders. The hallmark of neuroinflammation is the acti-
vation of resident glial cells and recruitment of peripheral
immune cells, as well as the production of pro-inflammatory
mediators. Activated glia are characterized by increased
cell proliferation, macrophage-specific activation marker
expression and bioactive mediator production, as well as by
morphological changes. In the CNS, the activation of glia,
including microglia and astrocytes, as a ubiquitous hall-
mark of different neuropathological states, is important in
forming an environment that contributes either to success-
ful repair of damaged brain tissue or to severe injury
of bystander cells. Although several activated glia-derived
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factors are thought to contribute to tissue repair, the
majority are believed to induce neurodegeneration via
mechanisms that are not yet fully understood (Giulian,
1993; Chao et al., 1995; Kong et al., 1996; Ridet et al., 1997).
Japanese encephalitis virus (JEV) belongs to the encepha-
litic flaviviruses and frequently causes acute encephalo-
pathy (Chambers et al., 1990). Although JEV causes
productive infection in most cell lines derived from
different tissue origins, clinical and animal studies suggest
that the principal target cells for JEV in the CNS are
neurons (German et al., 2006; Ghoshal et al., 2007). As a
result of infection, massive dysfunction and/or destruction
of neurons is a hallmark of JEV-associated encephalitis
(Kumar et al., 1990). Pathological features of JEV-
associated encephalitis also include inflammation-related
neuropathological complications. The recruitment and
activation of inflammatory cells in the lesion sites and
elevated levels of pro-inflammatory cytokines in the serum
and cerebrospinal fluid (CSF) have been observed in
Japanese encephalitis (Chaturvedi et al., 1979; Mathur
et al., 1988; Khanna et al., 1991; Ravi et al., 1997; Singh
et al., 2000). It has been demonstrated that the mortality
rate increases with increasing concentrations of cytokines
in the serum and CSF in Japanese encephalitis patients
(Ravi et al., 1997). Regarding JEV-associated neuroinflam-
mation, a number of studies have shown that JEV infects
microglia and astrocytes, and their consequent activation
contributes to neuronal death (Chen et al., 2000, 2004;
Raung et al., 2005, 2007; Abraham & Manjunath, 2006;
Bhowmick et al., 2007; Ghoshal et al., 2007; Mishra et al.,
2007; Das et al., 2008; Swarup et al., 2008). These studies
suggest that, in addition to direct viral infection of
neurons, bystander damage caused by activated microglia/
astrocytes is involved in JEV-induced neuronal death.
However, the extent to which glial cells are infected and
contribute to JEV-related pathogenesis has yet to be
determined.
Although activation of microglia and astrocytes is found
after JEV infection, activated microglia rather than
activated astrocytes are proposed to mediate severe
neurotoxicity (Raung et al., 2005; Ghoshal et al., 2007;
Mishra et al., 2007). Currently, the discrepancy between
JEV-activated microglia and astrocytes is not fully
understood. Therefore, in the present study, we investi-
gated cellular responses and alterations in microglia and
astrocytes after JEV infection in order to elucidate their
potential neurotoxic actions after activation.
RESULTS
JEV infection causes neuronal death
Neurotoxicity was assessed by morphological analysis and
cell counting after immunocytochemical staining for
microtubule-associated protein 2 (MAP-2). As shown in
Fig. 1(a), JEV infection caused degeneration of neurite
processes and decreased numbers of visible neurons in
cultures of neurons/glia (213±45 in mock vs 49±21 in
JEV, P,0.01). Demise of the neuronal body was not
detected in UV-inactivated (225±54) or boiling-inacti-
vated (201±49) JEV-infected cultures. In contrast to the
apparent neuronal damage, astrocytes were not signific-
antly affected by JEV infection. Microglia possessed a
process-bearing morphology (94.2±3.7%) in neuron/
glial cultures and changed into a rounded, darkly stained
cell morphology (93.6±4.5%) after JEV infection (Fig.
1b). Evidence suggests that this type of morphological
Fig. 1. Effect of JEV infection on neural cells. (a) Neuron/glial cultures were mock-infected or infected with JEV, UV-inactivated
JEV (JEV/UV) or boiling-inactivated JEV (JEV/boiled) for 48 h. Neuronal viability was detected by the immunoreactivity of
MAP-2. (b) Neuron/glial cultures were mock-infected or infected with JEV for 48 h. Neural cells were detected by the
immunoreactivity of MAP-2, GFAP and CD68. Representative micrographs are shown. Bars, 60 mm.
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switch represents a transformation from resting microglia
to reactive/amoeboid microglia (Ghoshal et al., 2007).
These results implied that neuronal death after JEV
infection was accompanied by the activation of glia,
especially microglia.
Activated glia contribute to JEV-induced neuronal
death
One of the neurotoxic mechanisms activated by glia involves
triggering bystander damage. To elicit this effect, the
supernatants were collected from mock- and JEV-infected
mixed glial cultures 48 h after infection. JEV infection
caused neuronal death in neuron cultures, as shown by the
change in the number of viable neurons (194±55 in control
vs 43±26 in JEV infection, P,0.01; Fig. 2a). Cell damage in
neuron cultures was observed after exposure to JEV-
conditioned medium (31±19, P,0.01). Intriguingly, the
neurotoxic action of JEV-conditioned medium was abol-
ished by boiling (211±57), but not by UV (36±21) pre-
treatment, before exposure (Fig. 2a). JEV-conditioned
medium showed a similar neurotoxic effect and action
characteristics in neuron/glial cultures. The numbers of
neurons in mock, JEV, JEV/UV and JEV/boiled cultures
were 209±35, 35±16, 68±34 and 203±55, respectively
(Fig. 2b). As with direct JEV infection, a morphological
change in the microglia (4.9±1.9% with a process-bearing
morphology, 94.8±3.7% with a rounded morphology) was
observed in neuron/glial cultures exposed to JEV-condi-
tioned medium when compared with mock-conditioned
medium (90.3±5.1% with a process-bearing morphology,
7.2±3.2% with a rounded morphology) (Fig. 2b). JEV-
conditioned medium pre-treated with UV still exerted a
morphological effect (5.1±2.9% with a process-bearing
morphology, 93.8±5.7% with a rounded morphology).
However, boiling pre-treatment disrupted the modulatory
effect of JEV-conditioned medium on microglial morpho-
logy (91.9±5.9% with a process-bearing morphology,
6.8±3.1% with a rounded morphology) (Fig. 2b). Thus,
JEV-conditioned medium from mixed glia contained
soluble mediators capable of triggering neuronal death and
microglial morphological changes.
Fig. 2. Effect of JEV-conditioned media on neural cells. The supernatants of mock-infected (Mock CM) and JEV-infected (JEV
CM) mixed glial cultures were collected 48 h after infection and mixed with an equal volume of fresh medium. The conditioned
media were added to cultured neurons (a) and neuron/glial cultures (b) for 24 h. JEV CM was also pre-treated with UV (JEV
CM/UV) or boiled (JEV CM/boiled) before adding to the cultured cells. Cultured neurons (a) were also directly infected with JEV
for 24 h (JEV). Neural cells were detected by the immunoreactivity of MAP-2 (a, b) and CD68 (b). Representative micrographs
are shown. Bars, 60 mm.
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JEV infection induces morphological changes in
microglia
Apparent morphological changes in microglia were
demonstrated in neurons/glia that were infected with JEV
or exposed to JEV-conditioned medium. To characterize
the morphological effects in more detail, mixed glial,
astrocyte and microglial cultures were investigated further.
In mixed glial cultures, 94.9±3.9% of the microglia had a
process-bearing morphology and 3.8±2.1% had a roun-
ded morphology. JEV infection transformed the microglia
from process-bearing to a rounded, darkly stained mor-
phology (5.1±2.8% with a process-bearing morphology,
92.8±3.1% with a rounded morphology) in mixed glial
cultures, similar to those composed of neurons/glia.
However, it was difficult to differentiate morphological
changes in astrocytes between mock- and JEV-infected cells
(Fig. 3). Cultured astrocytes exhibited a polygonal,
flattened morphology, and no detectable morphological
changes were observed after JEV infection (Fig. 3).
Intriguingly, unlike in neuron/glial cultures, microglia
alone had a small, rounded cell body (~25 mm in diameter)
without a process-bearing morphology under in vitro
culture conditions (Fig. 3). JEV infection caused cytoplas-
mic expansion (more than twice the cell volume) and
branches (3.1±1.6% in mock-infected vs 76.8±15.4% in
JEV-infected cells; Fig. 3). To determine whether replica-
tion-competent virus was essential for the induction of
these morphological changes, microglial cultures were
stimulated with UV- and boiling-inactivated JEV.
Boiling-inactivated JEV was unable to induce the morpho-
logical changes (2.9±1.3%), whereas UV-inactivated JEV
retained the same ability to transform microglial morpho-
logy (71.4±9.8) as wild-type JEV (Fig. 4). These findings
implied that virus amplification is not an essential
prerequisite for morphological modulation in JEV-infected
microglia.
JEV infection induces DNA synthesis in microglia
To verify the active proliferation of cells in response to
JEV infection, incorporation of 5-bromo-29-deoxyuridine
(BrdU) was determined. As illustrated in Fig. 5, elevated
BrdU incorporation was detected in neuron/glial
cultures exposed to JEV, whereas UV- and boiled-
inactivated JEV lost this inductive activity. The ability
of specific cells to respond directly to virus challenge was
tested in distinct cultures after inoculation with JEV.
Mixed glial and microglial cultures responded to JEV
infection by elevating BrdU incorporation. In contrast,
negligible proliferation was seen in astrocyte cultures after
JEV infection. Thus, microglia appeared to be the
dominant cells involved in active proliferation after JEV
infection.
JEV infection differentially induces cytokine
production in glia
The activation of glial cells yields multiple bioactive factors
leading to secondary glial activation and neuronal injury
(Giulian, 1993; Kong et al., 1996). To define the mecha-
nisms involved in the initiation of a pro-inflammatory
milieu in the CNS leading to eventual encephalitis, the
ability of JEV to induce pro-inflammatory mediator pro-
duction was measured. The results indicated a significant
upregulation of pro-inflammatory mediators such as
tumour necrosis factor (TNF)-a, interleukin (IL)-1b, IL-6
and RANTES (regulated upon activation, normal T-cell
expressed and secreted) in neuron/glial cultures after JEV
infection. Inactivation of JEV by UV and boiling
dramatically reduced the levels of these upregulated pro-
inflammatory mediators (Fig. 6a). The results suggested
that virus replication and/or productive infection is
probably required for upregulation of these pro-inflam-
matory mediators. Intriguingly, glia showed the distinct
expression profile of pro-inflammatory mediators in
response to JEV infection (Fig. 6b). The expression of
TNF-a, IL-1b, IL-6 and RANTES was elevated in JEV-
infected mixed glial and microglial cultures. Among the
four mediators, only the inductive production of IL-6 and
RANTES was demonstrated in JEV-infected astrocyte
cultures. These results indicated that JEV infection
selectively induces expression of certain pro-inflammatory
mediators in glial cells and that microglia show a relatively
higher immune competence.
Fig. 3. Appearance of glial cells after JEV
infection. Mixed glial, astrocyte and microglial
cultures were mock-infected or infected
with JEV for 48 h. Glial cells were detected
by the immunoreactivity of GFAP and CD68.
Representative micrographs are shown. Bars,
60 mm.
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Microglia rather than astrocytes contribute to
JEV-induced neuronal death
To elucidate the potential contribution of activated
astrocytes and microglia in JEV-induced neuronal death,
conditioned medium was collected from JEV-infected
microglia and astrocytes. As shown in Fig. 7, conditioned
medium from JEV-infected microglia (55±34) rather than
astrocytes (198±64) provoked significant neurotoxicity in
neuron cultures (mock, 215±59). The above-mentioned
studies demonstrated that microglia are the prominent
effector cells in response to JEV infection and that their
consequent activation provokes neuronal injury. What are
the potential neurotoxic mediators released by JEV-
infected microglia? Pro-inflammatory cytokines might be
a possibility. Therefore, to assess the involvement of glia-
derived pro-inflammatory cytokines in JEV-induced neu-
rotoxicity, neutralizing antibodies against TNF-a, IL-1b,
RANTES and IL-6 were used. The neurotoxic action of
supernatants from JEV-infected microglia was attenuated
by treatment with TNF-a or IL-1b neutralizing antibody.
However, attenuation of neurotoxicity was not observed
following treatment with control IgG or RANTES or IL-6
neutralizing antibody (Fig. 8). These results suggested that
microglia-derived TNF-a and IL-1b are involved in
neurotoxic cascades after JEV infection.
DISCUSSION
JEV-associated neurotoxicity has been well demonstrated
in clinical and animal studies (German et al., 2006; Ghoshal
et al., 2007). Although histochemical studies have revealed
microgliosis and astrogliosis in areas of neuronal damage,
Fig. 4. Appearance of microglia after JEV
infection. Cultured microglia were mock-
infected or infected with JEV, UV-inactivated
JEV (JEV/UV) or boiling-inactivated JEV (JEV/
boiled) for 48 h. Microglia were detected by
the immunoreactivity of CD68. Representative
micrographs are shown. Bar, 60 mm.
Fig. 5. BrdU incorporation assay. Neuron/glial
cultures were mock-infected or infected with
JEV, UV-inactivated JEV (JEV/UV) or boiled-
inactivated JEV (JEV/boiled) for 12 h. Mixed
glial, astrocyte and microglial cultures were
mock-infected or infected with JEV for 12 h.
Infected cells were labelled with BrdU (10 mM)
for an additional 24 h. The levels of BrdU
incorporation were detected by antibody
against BrdU and the absorbance was read
at 450 nm. *, P,0.05; **, P,0.01 vs mock,
n54 from different batches of preparations.
C.-J. Chen and others
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the inductive activation of microglia and astrocytes and the
consequences of this activation in Japanese encephalitis
have not yet been fully determined. In an animal model of
Japanese encephalitis, the elevated pro-inflammatory
mediator release by activated microglia was positively
correlated with neuronal death, and inhibition of microglia
activation resolved neuron inflammation and lethal
encephalitis (Ghoshal et al., 2007; Mishra & Basu, 2008),
implying a neurotoxic role of activated microglia. The
causative effect of activated microglia in JEV-associated
neuronal damage was demonstrated further by in vitro cell
line studies. JEV infection-stimulated and cytokine-acti-
vated microglial cell lines produced neurotoxic mediators
that caused neuronal death in neuronal cell lines (Ghoshal
et al., 2007; Das et al., 2008; Swarup et al., 2008). In parallel
with these findings, the present study elicited the inductive
characteristics of glia by JEV infection and showed the
neurotoxic potential of activated microglia via primary
culture models. These results further support the hypo-
thesis that JEV-associated neuronal loss is not only the
result of direct viral infection of neurons, but is also related
to bystander damage caused by activated microglia.
Fig. 6. Cytokine levels after JEV infection. (a) Neuron/glial cultures were mock-infected or infected with JEV, UV-inactivated
JEV (JEV/UV) or boiling-inactivated JEV (JEV/boiled) for 48 h. (b) Mixed glial, astrocyte and microglial cultures were mock-
infected or infected with JEV for 48 h. The supernatants were collected and subjected to ELISA for the measurement of TNF-a,
IL-1b, IL-6 and RANTES. **, P,0.01, n54 from different batches of preparations.
Neurotoxicity caused by JEV
http://vir.sgmjournals.org 1033
Downloaded from www.microbiologyresearch.org by
IP:  137.108.70.7
On: Thu, 07 Jul 2016 14:15:59
Primary neuron/glial cultures consist mostly of neurons,
astrocytes and microglia. This culture model enables the
researcher to study neurotoxicity. The degeneration of
neurite processes and loss of the neuronal body after
infection revealed the onset of JEV-associated neuronal
death in neuron/glial cultures (Figs 1 and 2). Neurotoxicity
is hypothesized to develop as a consequence of at least two
possibilities. The demise of neurons in neuron cultures
after JEV infection indicated that the cause of neurotoxicity
was direct viral infection of neurons (Fig. 2a). Mixed glia
are composed of astrocytes and microglia. The conditioned
medium of JEV-stimulated mixed glia (Fig. 2) and
microglia, but not of astrocytes (Fig. 7), was capable of
triggering neuronal death, indicating a critical role for the
bystander mechanism of neuronal death in JEV-associated
neurotoxicity. A previous study by us showed that JEV
preferentially infects neurons (~90%), microglia (~80%)
and astrocytes (~20–30%) based on immunopositivity of
viral antigen. Intriguingly, cultured primary neural cells
(neurons, ~104 p.f.u. ml21; astrocytes, ~103 p.f.u. ml21;
microglia, ~103 p.f.u. ml21) were not suitable permissive
cells compared with BHK21 cells (~108 p.f.u. ml21) for
productive replication of JEV (Chen et al., 2004). Despite
the low level of infectious virus particles, the severity of
neuronal death induced by conditioned medium was
similar to direct infection of neurons, indicating that the
observed cell death was not the result of the residual JEV
released from the infected cells. This hypothesis was further
supported by the neurotoxic potential of conditioned
medium pre-treated with UV irradiation (Fig. 2), after
which the presence of replication-active JEV was mini-
mized. These findings emphasize the importance of both
direct killing of neuronal cells by JEV and indirect neuronal
death induced by neurotoxic molecules released from JEV-
infected microglia in JEV neuropathogenesis. Currently,
the nature of the neurotoxin(s) released from JEV-
stimulated mixed glia and microglia has not been fully
characterized. The ELISA data (Fig. 6), together with data
reported in related studies, suggest that the neurotoxicity of
mixed glia- and microglia-conditioned medium was
primarily the consequence of molecules with neurotoxic
actions that were released from the infected cells. TNF-a
and IL-1b are potentially neurotoxic molecules in JEV-
associated neuronal death, as both neutralizing antibodies
attenuated JEV-induced neuronal death (Fig. 8) and both
Fig. 7. Effect of glia-derived conditioned medium on neurotoxicity.
The supernatants of mock-infected (Mock CM) and JEV-infected
microglia (JEV microglia CM) and JEV-infected astrocyte (JEV
astrocyte CM) cultures were collected 48 h after infection and
mixed with an equal volume of fresh medium. The conditioned
media were added to cultured neurons for 24 h. Neuronal viability
was detected by the immunoreactivity of MAP-2. Representative
micrographs are shown. Bar, 60 mm.
Fig. 8. Neurotoxic effect of released cytokines. Microglial cultures
were mock-infected (Mock CM) or infected with JEV (JEV CM) for
48 h and the supernatants collected. Supernatants isolated from
JEV-infected cells were modified by neutralization with control IgG
and TNF-a, IL-1b, RANTES and IL-6 neutralizing IgGs
(10 mg ml”1) for 30 min before mixing with an equal volume of
fresh medium. The modified conditioned media were added to
cultured neurons for 24 h. Neuronal viability was detected by the
immunoreactivity of MAP-2. The number of viable MAP-2
immunoreactive neurons is depicted. *, P,0.05; **, P,0.01, n54.
C.-J. Chen and others
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TNF-a and IL-1b have been shown to directly and
indirectly injure neurons (Raung et al., 2005, 2007;
Ghoshal et al., 2007; Swarup et al., 2007, 2008; Das et al.,
2008).
The effective control and ultimate clearance of invading
pathogens and removal of infected cells are critical in the
host response to infection. Unfortunately, over-reactivity
of host responses is also a key event leading to
neuropathological changes. The response to cerebral
infection with JEV is initiated by the activation of glia
with consequent production of pro-inflammatory medi-
ators, and is amplified by the recruitment of peripheral
inflammatory cells into the damaged brain. In addition to
neuronal damage, clinical and animal studies showed signs
of neuroinflammation such as inflammatory cell infiltra-
tion/activation and pro-inflammatory mediator produc-
tion at the lesion sites and in the peripheral circulation
(Chaturvedi et al., 1979; Mathur et al., 1988; Khanna et al.,
1991; Ravi et al., 1997; Singh et al., 2000; German et al.,
2006; Ghoshal et al., 2007). After infection of neuron/glial
cultures with JEV, neurotoxicity was accompanied by
concomitant activation of glia, as evidenced by morpho-
logical transformation (Figs 1 and 2), increased cell
proliferation (Fig. 5) and elevated pro-inflammatory
mediator production (Fig. 6). These cellular changes and
pro-inflammatory responses by JEV infection were similar
to those observed in other clinical and experimental studies
(Chaturvedi et al., 1979; Mathur et al., 1988; Khanna et al.,
1991; Ravi et al., 1997; Singh et al., 2000; German et al.,
2006; Ghoshal et al., 2007). The activation of glia and
induction of innate immunity appear to initiate and
propagate an irreversible immune response leading to
neuronal cell death in Japanese encephalitis. Glial activa-
tion by viruses has been demonstrated to be triggered by
several means, such as direct viral infection, released virus
particles, viral proteins, dsRNA, virus replication and
neuronal cell death, as well as other immune challenges.
Swarup et al. (2008) reported that TNF receptor-associated
death signalling mediated neuronal death, contributing to
the glial activation and neuroinflammation in Japanese
encephalitis. Thus, neuronal injury is a potent physio-
logical trigger of glial activation after JEV infection. In the
absence of neuronal cells, direct infection of mixed glia,
astrocyte and microglia cultures by JEV caused activation
of microglia and astrocytes (Figs 3–6). These findings
imply that direct viral infection is an alternative mech-
anism in triggering glial activation in Japanese encephalitis.
Replication-competent JEV infection caused neuronal
death (Fig. 1a), induced morphological change (Fig. 4),
stimulated cell proliferation (Fig. 5) and elevated pro-
inflammatory mediator production (Fig. 6a). Boiling-
inactivated JEV failed to cause neuronal death or induce
glial activation. Interestingly, UV inactivation blocked all
the effects caused by JEV, except for morphological
changes (Figs 1 and 4–6). These findings suggest that
morphological changes and cell proliferation/cytokine
expression in JEV-infected microglia can be triggered by
a distinct mechanism. Replication-competent JEV can
complete all these alterations. However, replication-
incompetent JEV retains its effect on morphological
changes, but loses its abilities in other tested activities.
The exact mechanisms of action underlying these differ-
ences and the potential diversity of morphological changes
were not addressed in this study. Phagocytosis-related
morphological changes may play a role, as activated and
phagocytic microglia were detected in JEV-infected brains
(German et al., 2006; Ghoshal et al., 2007) and higher
immunopositivity of viral antigen has been detected in
JEV-infected microglia by which cells were not recognized
as a preferential target for JEV infection (Chen et al., 2004).
Astrocytes and microglia are two essential cells within the
nervous system and possess a diversity of biological
activities. Astrocytes maintain homeostasis to support the
survival and function of neurons through trophic factor
release, inflammation modulation and metabolism regu-
lation (Norenberg, 1994; Ridet et al., 1997). Microglia play
an important role in immune surveillance, inflammatory
processes and tissue regeneration by releasing trophic
factors and inflammatory mediators and by phagocytosis
(Perry & Gordon, 1988; Gehrmann et al., 1995; Kreutzberg,
1996; Moore & Thanos, 1996). In responding to JEV
infection, microglia underwent morphological changes and
proliferation, and released biological mediators such as
TNF-a, IL-1b, RANTES and IL-6. In contrast, among the
cellular and biochemical alterations, JEV-infected astro-
cytes responded only by releasing RANTES and IL-6 (Figs
3–6). Among the differences observed between microglia
and astrocytes, the inability to release TNF-a and IL-1b
might partly explain the minor neurotoxic potential of the
conditioned medium of JEV-infected astrocytes (Figs 6–8).
Neurons, microglia and astrocytes all possess an intrinsic
ability to express TNF-a and IL-1b in response to various
stimuli in the CNS (Hanisch, 2002). Thus, cells can sense
JEV infection and transduce signals to switching molecules
in regulating cellular activity. Unlike microglia, JEV-related
sensing/signalling cascades were unable to switch on TNF-a
and IL-1b induction in astrocytes. Indeed, many studies
have demonstrated that astrocytes and microglia showed
distinct alterations in response to JEV infection. JEV
infection caused the release of TNF-a, IL-1b, IL-6, IL-18
and monocyte chemotatic protein-1 (MCP-1) in microglial
cell lines and expression of inducible nitric oxide synthase
and cyclooxygenase-2 (Ghoshal et al., 2007; Das et al.,
2008). JEV-infected astrocyte cell lines have been shown to
express IL-1b, IL-6, IL-8, IL-18, MCP-1 and IP-10 (Das
et al., 2008; Mishra et al., 2008). Animal and primary
culture studies have revealed that JEV infection elevates
expression of several genes in astrocytes, including IL-6,
MCP-1, RANTES, IP-10, glial fibrillary acidic protein
(GFAP), glutamate aspirate transporter, glutamate trans-
porter-1, nerve growth factor, ciliary neurotrophin factor
and brain-derived neurotrophic factor (Chen et al.,
2000; Bhowmick et al., 2007; Mishra et al., 2007). The
discrepancy between astrocytes and microglia in mediating
Neurotoxicity caused by JEV
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JEV-triggered TNF-a and IL-1b expression may be resolved
after completion of promoter reporter assay-related
studies. It should be noted that the distinct functional
outcome between astrocytes and microglia in this study
may be explained partly by differential viral load.
Currently, the critical molecules involved in distinct gene
expression profiles in microglia and astrocytes following
JEV infection have not yet been determined.
In conclusion, following JEV infection, neuronal death is
accompanied by concomitant microgliosis and astrogliosis.
Direct killing and bystander damage to neurons contribute
to JEV-associated neurotoxicity. In addition to injured
neurons, direct viral infection and cytokines are implicated
in glial activation, particularly in microglia. Microglia and
astrocytes respond to JEV infection by showing distinct
alterations such as morphological changes, cell prolifera-
tion and pro-inflammatory mediator production. Taken
together, our findings further suggest that numerous pro-
inflammatory mediators, such as TNF-a and IL-1b,
released by JEV-activated microglia rather than by JEV-
activated astrocytes, have the ability to amplify the
microglial response and cause neuronal death. However,
more research is required to elicit the exact causative
mechanisms and to identify the determinant switching
signalling for the diversity of distinct responses between
astrocytes and microglia following JEV infection.
METHODS
Virus infection. A local Taiwanese strain of JEV, strain NT113 isolated
from mosquitoes, was propagated in C6/36 cells utilizing Dulbecco’s
modified Eagle’s medium (DMEM) containing 5% fetal bovine serum
(FBS) (Chen et al., 2004). To infect cells, JEV was adsorbed to cultured
neural cells at an m.o.i. of 20 for 1 h at 37 uC. After adsorption,
unbound virus was removed by gentle washing with PBS. Fresh
medium was added to each plate for further incubation at 37 uC.
Cell cultures. The protocol for animal studies was approved by the
Animal Experimental Committee of Taichung Veterans General
Hospital, Taiwan. Cultures of neurons/glia, mixed glia, neurons,
microglia and astrocytes were prepared from the cerebral cortices of
1-day-old Sprague–Dawley rats (Chen et al., 2004). In brief, the
dissociated cells were plated on poly(D-lysine)-coated (20 mg ml21)
96-well or 24-well plates or 6 cm dishes at a seeding density of
2.06104 cells per well, 1.06105 cells per well or 2.06106 cells per
dish, respectively. One day after seeding, the culture medium was
replaced with minimum essential medium supplemented with 10%
FBS and 10% horse serum. After 4 days, the medium was changed
and replaced with fresh serum-containing medium. For cortical
neurons, the culture medium was replaced with neurobasal medium
supplemented with B27. Cytosine arabinoside (10 mM) was added to
the medium on days 3 and 4 to inhibit non-neuronal cell division.
These neuron/glia and neuron cultures were used for experiments
after 10–12 days of culture. For mixed glia, the cell pellets were
resuspended in DMEM/F-12 Nutrient Mixture (Invitrogen) supple-
mented with 10% FBS and penicillin/streptomycin. The medium was
replenished 4 days after plating and changed every 3 days. The
resultant mixed glial cultures were used 14–16 days after plating.
Astrocyte and microglial cultures were separated by shaking mixed
glial cultures at a speed of 200 r.p.m. for 24 h. The retained astrocytes
and detached microglia were replated and maintained in DMEM/F12
containing 10% FBS. Cell composition was identified and estimated
by immunocytochemistry using antibodies against MAP-2 for
neurons (Transduction Laboratories), GFAP for astrocytes (Santa
Cruz Biotechnology) and CD68 for microglia (BioSource). In general,
neuron/glial cultures consisted of 30–40% neurons, 40–45%
astrocytes and 10–15% microglia. Mixed glial cultures contained
~85% astrocytes and ~15% microglia. The purities of the neurons,
astrocytes and microglia were all greater than 95%.
Conditioned medium treatment. Mixed glial, astrocyte and
microglial cultures were mock-infected or infected with JEV for
48 h. The supernatants were collected and mixed with an equal
volume of fresh DMEM/F12 containing 1% FBS, referred to as
conditioned medium in this study. The conditioned medium was
modified by UV exposure (254 nm exposure for 30 min), boiling
(94 uC incubation for 15 min) or the addition of neutralizing
antibody for 30 min (control, TNF-a, IL-1b, RANTES or IL-6 IgG
at 10 mg ml21).
Immunocytochemical staining. The tested cells (in 24-well plates)
were washed twice with PBS, fixed with 4% paraformaldehyde in
phosphate buffer (0.1 M Na2HPO4, 0.1 M NaH2PO4) for 10 min,
permeabilized with 0.1% Triton X-100 for 15 min and washed with
PBS. The cells were blocked with 5% skimmed milk in PBS for
30 min. The cells were then incubated with primary antibody
overnight at 4 uC, followed by washing with PBS. After washing,
the cells were incubated with horseradish peroxidase-conjugated
secondary antibody for 1 h at room temperature. After washing, the
colour was developed with 3,39-diaminobenzidine and observed by
light microscopy.
Microscopic analysis. A visible cell body and a length of neurite
process greater than two cell bodies defined MAP-2-positive neurons.
For the quantification of neurons, the data were expressed as number
of cells per 0.5 mm2. Three fields with a surface area of 0.5 mm2 were
randomly selected and counted in a well of a 24-well plate. Microglia
were characterized by their process-bearing morphology and
rounded, darkly stained cell morphology in neuron/glial and mixed
glial cultures. Microglia possessing a small, rounded cell body
(~25 mm in diameter) without a process-bearing morphology and
cytoplasmic expansion (more than twice the cell volume) and
branches were noted in the microglial cultures. For the quantification
of microglia, the total number of CD68-positive cells was counted in a
well of a 24-well plate. Four replicates were conducted for each
experiment. Complete experiments were carried out using three
different batches of preparations.
BrdU incorporation. Cell proliferation and cellular DNA synthesis
were evaluated by assessing the levels of BrdU incorporation,
according to the manufacturer’s instructions (Amersham Pharmacia
Biotech). Briefly, cells were labelled with BrdU (10 mM) for 24 h after
JEV infection. After fixation and permeabilization, cells were
incubated with horseradish peroxidase-labelled BrdU antibody at
room temperature for 1 h. The immune complexes were detected by a
subsequent 3,39,5,59-tetramethylbenzidine reaction, and the absor-
bance of the resultant colour was read at 450 nm in a microtitre plate
spectrophotometer.
ELISA. The levels of TNF-a, IL-1b, IL-6 and RANTES in the
supernatants were measured using an ELISA kit according to the
manufacturer’s instructions (R&D Systems).
Statistical analysis. Data are expressed as mean values±SD.
Statistical analysis was carried out using one-way analysis of variance,
followed by Dunnett’s test to assess the statistical significance between
treated and untreated groups in all experiments. A level of P,0.05
was considered statistically significant.
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